Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanqi Lei

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Advanced Healthcare Materials|September 20, 2022
Effective Sonosensitizer Delivery by Redox Sensitive Nanoparticles for Prostate Cancer Sonodynamic Therapy via Amplifying Oxidative Stress and PeroxidationTongyu Tong, Hanqi Lei, Shiqiang Zhang, et al.
Cancer Letters|December 11, 2025
High-fat diet induced ECM remodeling attenuates chemosensitivity in prostate cancer via activating Piezo1-dependent mitochondria-ER contactsYupeng Guan, Fei Cao, Yusheng Luo, et al.
Advanced Healthcare Materials|November 22, 2023
Delivery of mRNA Vaccine with 1, 2-Diesters-Derived Lipids Elicits Fast Liver Clearance for Safe and Effective Cancer ImmunotherapyYuandong Xu, Yuexiao Hu, Heng Xia, et al.
Nano Letters|August 26, 2024
Acidity-Actuated Polymer/Calcium Phosphate Hybrid Nanomotor (PCaPmotor) for Penetrating Drug Delivery and Synergistic Anticancer ImmunotherapyBin Xu, Hanqi Lei, Tongyu Tong, et al.
Oncogene|August 23, 2025
HOMER3 orchestrates SRC-YAP1 activity that promotes tumor cell growth and antagonizes anti-tumor immunotherapy in prostate cancerTongyu Tong, Hanqi Lei, Mengjun Huang, et al.
Cell Death & Disease|July 28, 2021
CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancerHanqi Lei, Zifeng Wang, Donggen Jiang, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 27, 2021
CDK7 blockade suppresses super-enhancer-associated oncogenes in bladder cancerYafei Yang, Donggen Jiang, Ziyu Zhou, et al.
Research (Washington, D.C.)|December 15, 2025
CDK12-Mediated Phosphorylation of FOXA1 Promotes Prostate Cancer Progression via the MDM2-p53 AxisBinyuan Yan, Mengjun Huang, Jinxiang Wang, et al.
Cell Proliferation|July 3, 2025
CDK12 Inactivation Attenuates Prostate Cancer Progression by Inhibiting BNIP3-Mediated MitophagyMengjun Huang, Hanqi Lei, Tongyu Tong, et al.
Cancer Immunology, Immunotherapy : CII|July 12, 2025
TGF-β3 promotes vascular normalization of prostate cancer to potentiate immunotherapy and chemotherapyQiliang Teng, Niu Wang, Hanqi Lei, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Advanced Healthcare Materials|September 20, 2022
Effective Sonosensitizer Delivery by Redox Sensitive Nanoparticles for Prostate Cancer Sonodynamic Therapy via Amplifying Oxidative Stress and PeroxidationTongyu Tong, Hanqi Lei, Shiqiang Zhang, et al.
Cancer Letters|December 11, 2025
High-fat diet induced ECM remodeling attenuates chemosensitivity in prostate cancer via activating Piezo1-dependent mitochondria-ER contactsYupeng Guan, Fei Cao, Yusheng Luo, et al.
Advanced Healthcare Materials|November 22, 2023
Delivery of mRNA Vaccine with 1, 2-Diesters-Derived Lipids Elicits Fast Liver Clearance for Safe and Effective Cancer ImmunotherapyYuandong Xu, Yuexiao Hu, Heng Xia, et al.
Nano Letters|August 26, 2024
Acidity-Actuated Polymer/Calcium Phosphate Hybrid Nanomotor (PCaPmotor) for Penetrating Drug Delivery and Synergistic Anticancer ImmunotherapyBin Xu, Hanqi Lei, Tongyu Tong, et al.
Oncogene|August 23, 2025
HOMER3 orchestrates SRC-YAP1 activity that promotes tumor cell growth and antagonizes anti-tumor immunotherapy in prostate cancerTongyu Tong, Hanqi Lei, Mengjun Huang, et al.
Cell Death & Disease|July 28, 2021
CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancerHanqi Lei, Zifeng Wang, Donggen Jiang, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 27, 2021
CDK7 blockade suppresses super-enhancer-associated oncogenes in bladder cancerYafei Yang, Donggen Jiang, Ziyu Zhou, et al.
Research (Washington, D.C.)|December 15, 2025
CDK12-Mediated Phosphorylation of FOXA1 Promotes Prostate Cancer Progression via the MDM2-p53 AxisBinyuan Yan, Mengjun Huang, Jinxiang Wang, et al.
Cell Proliferation|July 3, 2025
CDK12 Inactivation Attenuates Prostate Cancer Progression by Inhibiting BNIP3-Mediated MitophagyMengjun Huang, Hanqi Lei, Tongyu Tong, et al.
Cancer Immunology, Immunotherapy : CII|July 12, 2025
TGF-β3 promotes vascular normalization of prostate cancer to potentiate immunotherapy and chemotherapyQiliang Teng, Niu Wang, Hanqi Lei, et al.
Pageof 4